AFP and hepatocellular carcinoma: As the most widely used biomarker for HCC, AFP has limited specificity and sensitivity (Bruix & Sherman, 2011; Marrero et al., 2009), and was also elevated in non‐HCC malignancies (Crawford & Burt, 2012; Cui et al., 2016).